Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
26-10-06	€0.6400	0.00%
26-10-05	€0.6400	0.00%
26-10-02	€0.6400	0.00%
26-10-01	€0.6400	0.00%
26-09-30	€0.6400	0.00%

Real-time Euronext Paris

More quotes

Real-time Euronext Paris 11:55:00 2026-10-06 am EDT			5-day change	1st Jan Change
0.6400 ^EUR	0.00%		0.00%	-63.43%

Jun. 30	Safe Group sharply improves its full-year results
Jun. 28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 144K 119K 108K 204K 13.85M 206K 1.43M 557K 7.06M 539K 528K 22.71M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 14.91M 12.39M 11.23M 21.21M 1.44B 21.36M 149M 57.88M 733M 55.98M 54.78M 2.36B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

Jun. 30	Safe Group sharply improves its full-year results
Jun. 28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
May. 28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
May. 28	Safe Group enters Peru with exclusive distribution agreement
Mar. 16	Changes to the SAFE Board of Directors
Dec. 17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
Dec. 17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
Nov. 30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

Dec. 22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
Dec. 17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
Dec. 17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news: Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Sep. 08	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
Aug. 25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
Jun. 30	Safe Group améliore nettement ses résultats annuels
May. 28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
Apr. 28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	141,014.1
5 years	0.54	4,656,449,953.44
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	144K
ABBOTT LABORATORIES	-1.94%	-2.76%	-26.60%	+1.32%	170B
MEDTRONIC PLC	-1.00%	0.00%	-11.52%	+14.41%	111B
STRYKER CORPORATION	-2.46%	-0.20%	-24.05%	+4.65%	107B
ESSILORLUXOTTICA	-0.58%	+0.17%	-47.23%	-10.69%	75.95B
CENCORA, INC.	+0.46%	+2.85%	+3.63%	+72.08%	60.37B
HOYA CORPORATION	-0.65%	+6.59%	+11.44%	+66.40%	53.53B
BECTON, DICKINSON AND COMPANY	-0.20%	-0.92%	-6.09%	-31.29%	49.11B
IDEXX LABORATORIES, INC.	-2.21%	-3.38%	-17.90%	+15.57%	40.6B
DEXCOM, INC.	-4.04%	-3.75%	+25.66%	+0.20%	31.47B
Average	-0.70%	+0.22%	-16.60%	+3.27%	69.9B
Weighted average by Cap.	-0.46%	-0.04%	-16.23%	+12.19%

	2024	2025
Net sales	5.04M 5.68M 4.72M 4.28M 8.08M 547M 8.13M 56.66M 22.04M 279M 21.32M 20.86M 898M	5.36M 6.04M 5.02M 4.55M 8.59M 582M 8.65M 60.29M 23.45M 297M 22.68M 22.2M 955M
Net income	-1.93B -2.17B -1.81B -1.64B -3.09B -210B -3.11B -21.68B -8.43B -107B -8.16B -7.98B -344B	-4.67M -5.27M -4.37M -3.96M -7.49M -508M -7.54M -52.53M -20.43M -259M -19.76M -19.34M -832M
Net Debt	11.47M 12.92M 10.73M 9.73M 18.38M 1.25B 18.51M 129M 50.15M 635M 48.5M 47.46M 2.04B	13.11M 14.77M 12.27M 11.12M 21M 1.42B 21.16M 147M 57.32M 726M 55.44M 54.25M 2.34B